Maximize Returns with AI-Powered MESO Insights

AI MESO Forecast

Price Forecast:

Bearish <-> Bullish

Bullish Case: Positive FDA approval for remestemcel-L could significantly boost MESO. High options volume and elevated implied volatility indicate market optimism, suggesting a price rally ahead.

Bearish Case: Continued regulatory delays or negative trial results could lead to further declines in MESO. The high implied volatility may reflect underlying market fear, potentially causing sharp sell-offs.

Potential Outcomes:

1. 65% chance of FDA approval boosting MESO prices (>30% increase).

2. 25% chance of FDA delays/rejections leading to stagnant or declining prices.

3. 10% chance of unforeseen financial crises destabilizing the stock further.

Trading Oracle: Sign Up to access trading oracle trade ideas.

September 24, 2024

Mesoblast Forecast

MESO Mesoblast

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with MESO

CQQQ Invesco China Technology (0.85)

AMC AMC Entertainment (0.77)

ADM Archer Daniels Midland (0.76)

CWEB Direxion Daily CSI China Internet Index Bu (0.72)

CRK Comstock Resources (0.72)

Uncorrelated Assets

Assets with little price relationship to MESO

MGY Magnolia Oil & Gas Corp (-0.0)

ES Eversource Energy (-0.0)

SRE Sempra Energy (0.0)

SNY Sanofi (0.0)

RMBS Rambus (-0.0)

Anticorrelated Assets

Assets that tend to move strongly against MESO

ARDX Ardelyx (-0.79)

BHVN Biohaven Pharmaceutical (-0.81)

VTRS Viatris (-0.81)

CYTK Cytokinetics (-0.82)

ABT Abbott Laboratories (-0.84)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.